Join leading experts Dr. Joshua Brody, Dr. Tara Graff, Dr. Paolo Strati and Dr. Kirollos Hanna for this accredited virtual webinar. This is a 90-minute live-virtual, faculty-led summit designed to address the real-world operational and clinical challenges of integrating bispecific antibodies into community oncology practice for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) and follicular lymphoma (R/R FL). Moving beyond clinical efficacy data, this case-based program emphasizes practical decision-making, multidisciplinary workflows, and implementation strategies to help community practices build sustainable, bispecific-ready care models. Participants will evaluate appropriate patient selection criteria and treatment sequencing including positioning bispecific therapies relative to CAR-T and other emerging options while mastering operational protocols for step-up dosing, monitoring, and outpatient administration. Through interactive case discussions and live decision-point polling, attendees will also gain evidence-based strategies to recognize, grade, and manage adverse events such as cytokine release syndrome (CRS), ICANS, and infectious complications.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Conference / congress
- Credit · Up to 1.5 credits
- Commercial Support
-
WhenOct 28, 2026
-
MedAll +1 BRIDGE Community Oncology Readiness Academy | Workshop 1: Selecting the Right Patient at the Right Time
-
MedAll +1 BRIDGE Community Oncology Readiness Academy | Workshop 4: Building a Bispecific-Ready Practice
-
MedAll +1 BRIDGE Community Oncology Readiness Academy | Workshop 2: From Prescription to First Dose
-
PRIME Education, Inc. (PRIME®) A Roadmap to Accelerate the Evidence-Based Integration of Bispecific Antibody Therapies Into DLBCL/FL Care Plans
-
Physicians’ Education Resource (CME Track) Community Practice Connections(TM): Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma
-
Smart Patients +1 InterACT Oncology Team Training Integrating Bispecific Antibodies Into PatientCentered Management of DLBCLEnhancing the PatientProvider Therapeutic Connection
